Rankings
▼
Calendar
▼
COEP Q1 2020 Earnings Report — Coeptis Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
Coeptis Therapeutics, Inc.
COEP
Q1 2020 Earnings
Reported March 30, 2020
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q1 2020
Q4 2019
Q1 2019
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
$0
—
—
—
—
EPS (Diluted)
$0.00
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$0
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$0
Other Expenses
$0
Operating Expenses
$0
Cost & Expenses
$0
OPERATING INCOME
$0
Interest Income
$2
Interest Expense
$0
Other Income/Expenses
$2
INCOME BEFORE TAX
$2
Income Tax Expense
$0
Net Income from Continuing Ops
$2
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
$2
Net Income Deductions
$0
BOTTOM LINE NET INCOME
$2
D&A
$0
EBIT
$2
EBITDA
$2
EPS
$0
EPS Diluted
$0
marketcaparena.com
← FY 2020
COEP Overview
Q2 2020 →